Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
4.060
+0.095 (2.40%)
Sep 12, 2025, 4:27 PM CET
2.40%
Market Cap1.43B
Revenue (ttm)100.00K
Net Income (ttm)-58.91M
Shares Out352.99M
EPS (ttm)-0.22
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,120,130
Average Volume4,224,720
Open3.980
Previous Close3.965
Day's Range3.850 - 4.085
52-Week Range0.956 - 4.990
Beta0.11
RSI83.23
Earnings DateAug 29, 2025

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 9
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.